Author: Leah Stern

[PRESS RELEASE] Ourcrowd appoints Hasanat Dewan as chief innovation officer, plans global AI innovation center

JERUSALEM, March 10, 2021 –  OurCrowd, the leading venture investing platform and Israel’s most active venture investor, today announced the appointment of Dr. Hasanat Dewan as Chief Innovation Officer.  Dr. Dewan will oversee the development and deployment of OurCrowd’s strategic next-generation platform, supporting a broad-based network of stakeholders and enabling investors unprecedented access to venture capital and other private markets. Read more...

Read More

PRESS RELEASE: Sight Diagnostics Raises $71M To Accelerate Global Expansion of itsFDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer

Sight Diagnostics Raises $71M To Accelerate Global Expansion of its FDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer The investment from Koch Disruptive Technologies, Longliv Ventures, a member of the CK Hutchison Holdings and OurCrowd will fuel Sight’s R&D into the automated identification and detection of diseases Tel Aviv, Israel (August 5, 2020) – Sight DiagnosticsⓇ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million in Series D funding with participation from Koch Disruptive Technologies, Longliv Ventures and OurCrowd. This new round brings Sight’s total funding to more than $124 million and will support the expansion of Sight’s commercial operations globally and advance Sight’s R&D into the detection of additional diseases as well as biomarkers indicating COVID-19 severity. “We firmly believe that Sight’s method of using machine vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a...

Read More

PRESS RELEASE: OURCROWD RELEASES NEW SOCIAL INVESTOR APP AT FINOVATE SPRING 2016

MATERIALS FOR RELEASE: PDF download here Photos and logos ZIP file download here OURCROWD RELEASES NEW SOCIAL INVESTOR APP AT FINOVATE SPRING 2016 Launch of OurCrowd App provides investors with unprecedented access to deal-flow, real-time investment information, and greater connectivity to OurCrowd’s 12,000 strong global community   — Jerusalem/San Jose, May 11, 2016 – OurCrowd, announces a significant expansion of its leading global equity crowdfunding platform with its new social investor app today at FinovateSpring 2016 in San Jose, with a demo alongside some of the world’s top Fintech startups. OurCrowd’s new app gives investors the ability to make informed investment decisions ranging from $10,000 to $10M right from their mobile phone. Private deal rooms will harness the power of the crowd, providing access to OurCrowd’s 12,000-strong (and growing) member community to collaborate and receive input on investments from friends and experts in their social networks. “Until now, private investing has been conducted in a very traditional, old fashioned and often inefficient way. We are bringing the benefits of connected mobile commerce to the start-up investing market,” said OurCrowd’s...

Read More

PRESS RELEASE: SWEETCH HEALTH RAISES $3.5M TO DEPLOY LARGE SCALE PERSONALIZED DIABETES PREDICTION AND PREVENTION PLATFORM

MATERIALS FOR RELEASE: PDF download here Photos and logos ZIP file download here SWEETCH HEALTH RAISES $3.5M TO DEPLOY LARGE SCALE PERSONALIZED DIABETES PREDICTION AND PREVENTION PLATFORM — Jerusalem, Israel —April 7, 2016—  Sweetch Health, which has developed a “digital vaccine” for diabetes, has raised $3.5 million in a Series A round led by Philips, a leading health technology company, and OurCrowd, a leading equity crowdfunding platform.  Participation from prior investors also included Pontifax L.P. and Lionbird L.P. Sweetch Health, an Israeli digital health start-up, has developed a revolutionary platform that assists in identifying individuals at risk of developing diabetes and coaching to prevent diabetes and other chronic conditions. Current funding will be used to complete a pilot program and clinical trials soon to begin at a major international medical institution and jump start commercialization in the USA. Upon completion, Sweetch will be well positioned to be “prescribed” by medical team personnel worldwide. OurCrowd’s CEO Jon Medved stated that “given the recent announcement by the US Secretary of Health and Human Services regarding Medicare coverage of diabetes prevention programs, the latest...

Read More

PRESS RELEASE: UOB Partners with OurCrowd to Provide Equity Crowdfunding in Asia

MATERIALS FOR RELEASE: PDF download here Photos and logos ZIP file download here UOB PARTNERS WITH OURCROWD TO PROVIDE EQUITY CROWDFUNDING IN ASIA Singapore/Jerusalem, March 3, 2016 –  United Overseas Bank Limited (UOB) today announced Asia’s first strategic partnership with a leading global equity crowdfunding platform, OurCrowd. It pairs the Bank’s strengths and depth of experience in serving entrepreneurs as well as small and medium-sized enterprises (SMEs) across the region with OurCrowd’s expertise in investing in some of the world’s most promising startups through equity crowdfunding. The collaboration will see UOB making a US$10 million investment in OurCrowd. The accredited investors among UOB’s clients will now have an opportunity to broaden their investments into OurCrowd’s portfolio companies. Through this collaboration, innovative Asian companies with differentiated and highly scalable technology products and services will now get access to another source of funding through OurCrowd’s equity crowdfunding platform. Through equity crowdfunding, they can seek relatively small investments from a large number of investors in return for equity or shares in their startup company. It provides them with the funding needed to develop...

Read More